Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B

Triazole resistant A. fumigatus has been documented in many parts of the world. In the Netherlands, incidence is now above 10% and results in the need for long-term parenteral therapy with liposomal amphotericin B (LAmB). The long terminal half-life of LAmB suggests that intermittent dosing could be...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Peppel, Robert J, Schauwvlieghe, Alexander, Van Daele, Ruth, Spriet, Isabel, van't Wout, Jan W, Brüggemann, Roger J, Rijnders, Bart J A, Hendriks, Bart J C, de Boer, Mark G J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527269/
https://www.ncbi.nlm.nih.gov/pubmed/31965178
http://dx.doi.org/10.1093/mmy/myz134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527269/
https://www.ncbi.nlm.nih.gov/pubmed/31965178
http://dx.doi.org/10.1093/mmy/myz134

Ejemplares similares